Why FDA put the pedal to the metal for radar and hummingbirds and why medtech needs Google - MassDevice

DeviceTalks WeeklyIn this week’s episode of DeviceTalks Weekly, co-hosts Chris Newmarker and Tom Salemi dig into the recent successes by startups Circadia Health and Preceptis Medical, which both saw expedited approval from the FDA due to the pandemic.

Circadia Health earned a spot on this year’s “20 medical device startups you need to know” list.

Circadia CEO Fares Siddiqui discusses the quick approval that came for his company’s C100 system that uses radar to monitor respiratory function.

Preceptis Medical CEO Steve Anderson, meanwhile, explains why the agency – and he hopes payers – want to see his company’s ear-tube implanting system on the market.

We also visit with Heidi Dohse, senior program manager at Google’s Cloud Healthcare & Life Sciences organization, who will be leading the upcoming DeviceTalks Tuesday’s discussion about how medtech devices can use data to better serve its sickest patients.

Register for the free discussion here.

Dohse partners with physicians and researchers around the world to provide insights regarding the patient experience and ideas for engagement. She travels globally educating audiences on digital health, data and healthcare. On Tuesday, she’ll discuss.

Don’t miss an episode! Subscribe to DeviceTalks Weekly on your podcast players.

 

 

DeviceTalks by MassDevice · Why FDA put the pedal to the metal for radar and hummingbirds. And why medtech needs Google.

RSS From Medical Design & Outsourcing

  • 3D Systems lands FDA clearance for ankle replacement system
    3D Systems recently announced that the FDA granted 510(k) clearance for the Vantage Ankle PSI, a patient-specific, total ankle surgical planning system with 3D-printed instruments. The 3D-printed instrument set is designed to guide resections in the tibia and talus for total ankle replacement surgery using Exactech’s Vantage total ankle system. Vantage Ankle PSI may increase… […]
  • BREAKING: FDA says Pfizer’s COVID-19 vaccine meets success criteria
    The FDA today said that the COVID-19 vaccine candidate made by Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) meets success criteria. Ahead of an advisory meeting on Thursday, Dec. 10, to review the vaccine candidate, the FDA found that data from Pfizer and BioNTech’s trials was “consistent” with its recommendations for emergency use ization and that the candidate was… […]
  • How did medtech companies score on environmental stewardship list?
    Medical Design & Outsourcing recently rated the world’s largest medical device companies — the Big 100 — for their sales numbers and R&D spend. Now we can share how some of them scored on an environmental nonprofit’s annual list of companies ranked for their actions on climate change. Not-for-profit organization CDP (Stockholm, Sweden) runs a… […]
  • Telemedicine in the Operating Room: The ‘New Normal’ for MedTech
    By Jerry Carter, Avail Medsystems There is incredibly high demand for collaboration during medical procedures – whether it’s a Cardiologist advising a more junior physician on a complex procedure, a renowned surgeon training other colleagues on a technique, a medical device company rolling out a new product, or a medical device rep providing product support… […]
  • Tilak inks distro deal with Novartis for vision app
    Tilak Healthcare announced today that it entered into a framework agreement with Novartis (NYSE:NVS) to promote its OdySight remote monitoring app. Paris-based Tilak’s OdySight is a smartphone application designed to monitor and engage patients with age-related chronic eye diseases. The app is available by prescription and includes vision tests and puzzles to boost engagement while strengthening… […]
  • Carlsmed lands breakthrough nod for spinal correction device
    Carlsmed today said it received FDA 510(k) clearance and breakthrough device designation for its Aprevo patient-specific interbody devices to correct adult spinal deformity. Aprevo is a spinal device that is designed to provide more effective treatment of an irreversibly debilitating condition than current standards of care, according to the company. “Today’s announcement is great for… […]
  • Clinical study sponsors may become non-EU post-Brexit
    By Ronald Boumans, Emergo Group The departure of the United Kingdom from the European Union on January 1, 2021, has many consequences. Clinical investigations with medical devices as well as clinical performance studies with in vitro diagnostic devices are impacted, as are clinical studies with medicinal products. In this respect, Brexit means that sponsors and… […]
  • Wytech Industries names CFO
    Specialty and precision wire manufacturer Wytech Industries (Rahway, N.J.) announced it has named Henry Burmeister chief financial officer. Burmeister has a finance and operational background in medical device contract manufacturing. He has held leadership roles focusing on medical device contract manufacturing, design/development, and specialty chemicals. Most recently, he served as Viant Medical’s VP of finance… […]
  • Cantel Medical, Censis Technologies partner on scope reprocessing software
    Cantel Medical (NYSE:CMD) and Censis Technologies today announced a new long-term partnership to combine Cantel’s endoscope reprocessing workflow portfolio with the Censis surgical device management and instrument-tracking software from Censis. The new, co-branded product will combine Cantel’s Canexis integrated workflow software for endoscopy with Censis’ CensiTrac surgical asset management program. The combined software will provide quality… […]
  • Motion Dynamics acquires ViaMed
    Motion Dynamics recently announced the acquisition of ViaMed Holdings, a manufacturer of custom, micro-precision components and subassemblies for the medical device industry. Fruitport, Mich.-based Motion Dynamics makes wire-based micro-components and sub-assemblies for the medical device, industrial and aerospace industries, specializing in micro-catheters, pacemakers and neuromodulation devices. Private equity player Vance Street Capital invested an unspecified… […]
  • Webinar: How tubing selection affects dosing accuracy in medical pump applications
    Wednesday, January 13, 2020 11:30 a.m. Eastern time / 8:30 a.m. Pacific time     Adverse drug events (ADE’s) stemming from peristaltic pumping play a significant role in today’s healthcare. Choosing the correct material and minimizing the dimensional variation of your tubing are critical aspects to reducing potential ADE. Through our pump studies and novel… […]